THE COMPREHENSIVE CANCER CENTER AT OUR LADY OF MERCY MEDICAL CENTER REPORTS PROMISING RESULTS USING REVLIMID IN NON-HODKINS LYMPHOMA PATIENTS
   
OUR LADY OF MERCY’S COMPREHENSIVE CANCER CENTER LAUNCHES NAVIGATOR PROGRAM TO HELP CANCER PATIENTS OVERCOME BARRIERS TO MEDICAL CARE
OUR LADY OF MERCY MEDICAL CENTER CANCER RESEARCHERS AWARDED GRANTS FOR CANCER RESEARCH
OUR LADY OF MERCY CANCER CENTER INITIATES A COMMUNITY EDUCATION PROGRAM ON THE BENEFITS OF PARTICIPATING IN CLINICAL TRIALS
NEW FEDERAL POLICY ADDS IMPORTANT CANCER TREATMENT OPTION
Increases Access To High-Dose Interleukin-2 (IL-2) Therapy For Certain Patients With Life-Threatening Cancers
Our Lady Of Mercy Cancer Center Oncologists Pioneered The Initial Use Of IL-2 In Renal Cell Carcinoma And Melanoma Completing The Earliest Trials Showing The Benefit Of Treatment

NATIONAL CANCER INSTITUTE ENCOURAGES NEW METHOD OF TREATMENT FOR ADVANCED OVARIAN CANCER PATIENTS BEING STUDIED AT OUR LADY OF MERCY’S COMPREHENSIVE CANCER CENTER.
FOOD AND DRUG ADMINISTRATION APPROVES ORAL KIDNEY CANCER TREATMENT STUDIED AT OUR LADY OF MERCY MEDICAL CENTER
THE COMPREHENSIVE CANCER CENTER AT OUR LADY OF MERCY MEDICAL CENTER PARTICIPATES IN NEW STUDY FOR ADVANCED RENAL CELL CARCINOMA
Access to Investigational Drug ‘Sorafenib’ Available In The Bronx
NATIONAL CANCER STUDY ON GINGER CONTROLLING NAUSEA
DURING TREATMENT TO BEGIN AT COMPREHENSIVE CANCER CENTER
AT OUR LADY OF MERCY MEDICAL CENTER

THE COMPREHENSIVE CANCER CENTER AT OUR LADY OF MERCY MEDICAL CENTER HONORED BY THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
  OUR LADY OF MERCY MEDICAL CENTER CELEBRATES CANCER SURVIVAL DAY
   
  CITYWIDE PROSTATE CANCER SCREENING
   
  UNIQUE BLOOD DISORDER STUDY UNDERWAY AT OUR LADY OF MERCY MEDICAL CENTER
 
OUR LADY OF MERCY’S COMPREHENSIVE CANCER CENTER PARTICIPATES IN NATIONWIDE STUDY ON THE GENETIC CAUSES OF CANCER
 
SELECT STUDY EVALUATES IMPACT OFSELENIUM AND VITAMIN E ON PROSTATE CANCER
   
  PIONEERING TECHNIQUE TO SCREEN LUNG CANCER AT EARLY AND MOST TREATABLE STAGE UNDERWAY AT OUR LADY OF MERCY CANCER CENTER
   
  OUR LADY OF MERCY COMPREHENSIVE CANCER CENTER DIRECTOR PETER WIERNIK, M.D. RECIPIENT OF GOLD MEDAL AT THEN FIRST POLISH NATIONAL CANCER CONGRESS FOR PROMOTING CANCER RESEARCH AND TREATMENT PROGRAMS IN POLAND
   
  CANCER RESEARCHERS PROPOSE A GENETIC BASIS FOR FAMILIAL NON-HODGKIN'S LYMPHOMA